Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+3.44%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$11.6B
AUM Growth
-$483M
(-4%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-6.43%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
617
New
162
Increased
103
Reduced
150
Closed
187
Top Buys
| 1 |
Delta Air Lines
DAL
|
+$154M |
| 2 |
AbbVie
ABBV
|
+$128M |
| 3 |
KeyCorp
KEY
|
+$119M |
| 4 |
Walmart
WMT
|
+$110M |
| 5 |
F5
FFIV
|
+$108M |
Top Sells
| 1 |
Oracle
ORCL
|
+$161M |
| 2 |
S&P Global
SPGI
|
+$149M |
| 3 |
Labcorp
LH
|
+$142M |
| 4 |
Eli Lilly
LLY
|
+$133M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$130M |
Sector Composition
| 1 | Technology | 19.25% |
| 2 | Healthcare | 13.54% |
| 3 | Industrials | 12.35% |
| 4 | Consumer Discretionary | 10.54% |
| 5 | Financials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Brixmor Property Group
BRX
$8.5B
| $1.1M | 0.01% |
61,591
-156,549
| -72% | -$2.8M |
|
|
PDCE
377
DELISTED
PDC Energy, Inc.
PDCE
| $1.09M | 0.01% |
25,312
-466,524
| -95% | -$20.1M |
|
378
Anywhere Real Estate
HOUS
$724M
| $1.09M | 0.01% |
+33,599
| New | +$1.09M |
|
379
Norfolk Southern
NSC
$61.8B
| $1.09M | 0.01% |
8,928
-289,276
| -97% | -$35.2M |
|
|
ACGN
380
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $1.07M | 0.01% |
4,596
-1,869
| -29% | -$437K |
|
|
SRC
381
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $1.07M | 0.01% |
32,279
-27,843
| -46% | -$926K |
|
|
SFR
382
DELISTED
Starwood Waypoint Homes
SFR
| $1.07M | 0.01% |
+31,086
| New | +$1.07M |
|
383
IPG Photonics
IPGP
$3.5B
| $1.05M | 0.01% |
7,235
-7,649
| -51% | -$1.11M |
|
384
WisdomTree
WT
$2B
| $1.03M | 0.01% |
+101,219
| New | +$1.03M |
|
385
vTv Therapeutics
VTVT
$49.1M
| $1.02M | 0.01% |
5,113
-155
| -3% | -$30.8K |
|
386
Asure Software
ASUR
$229M
| $1.01M | 0.01% |
+69,430
| New | +$1.01M |
|
387
East-West Bancorp
EWBC
$15.1B
| $1M | 0.01% |
+17,064
| New | +$1M |
|
|
CFRX
388
DELISTED
ContraFect Corporation
CFRX
| $999K | 0.01% |
861
-30
| -3% | -$34.8K |
|
389
Sangamo Therapeutics
SGMO
$158M
| $997K | 0.01% |
+113,301
| New | +$997K |
|
|
VLRX
390
DELISTED
VALERITAS HOLDINGS INC
VLRX
| $997K | 0.01% |
7,279
-221
| -3% | -$30.3K |
|
391
Neurocrine Biosciences
NBIX
$14.3B
| $979K | 0.01% |
21,280
-11,612
| -35% | -$534K |
|
|
JCAP
392
DELISTED
Jernigan Capital, Inc.
JCAP
| $978K | 0.01% |
+44,433
| New | +$978K |
|
393
Vertex Pharmaceuticals
VRTX
$101B
| $967K | 0.01% |
7,503
-112,686
| -94% | -$14.5M |
|
394
Timken Company
TKR
$5.37B
| $959K | 0.01% |
20,745
-564,406
| -96% | -$26.1M |
|
|
FOMX
395
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $955K | 0.01% |
205,870
-296,709
| -59% | -$1.38M |
|
396
SLM Corp
SLM
$6.35B
| $949K | 0.01% |
82,483
-2,002,910
| -96% | -$23M |
|
397
UroGen Pharma
URGN
$991M
| $903K | 0.01% |
+50,000
| New | +$903K |
|
|
MRTX
398
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $893K | 0.01% |
244,574
-7,414
| -3% | -$27.1K |
|
|
DOVA
399
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $780K | 0.01% |
+35,000
| New | +$780K |
|
|
BLRX
400
BioLineRX
BLRX
$15.6M
| $743K | 0.01% |
1,466
-2,284
| -61% | -$1.16M |
|